Menu

Kyoto University Finds Stem Cell Researcher Guilty of Data Fabrication

The scientist was a member of a stem cell research team led by Nobel laureate Shinya Yamanaka. 

Jan 25, 2018
Katarina Zimmer

FLICKR, JPELLGENUpdate (March 30): Kyoto University has fired Kohei Yamamizu, Retraction Watch reports. Shinya Yamanaka also received an as-yet-unknown penalty. 

Kyoto University announced the results of an investigation into research misconduct this week (January 22), finding one of its scientists—who was part of a research group headed by Nobel laureate Shinya Yamanaka—guilty of falsifying data in a study published in Stem Cell Reports last year. The university has requested that the journal retract the paper, Reuters reports.

The investigation concluded that the lead author of the paper, Kohei Yamamizu, had fabricated all six main figures of the study, which were “pivotal in the conclusions the author drew,” Yamanaka told a press conference (via Nikkei Asian Review). The authors had claimed success in modelling the blood-brain barrier in vitro using induced pluripotent stem (iPS) cells.

Yamamizu is an assistant professor in a research group led by Yamanaka at Kyoto University’s Center for iPS Cell Research and Application (CiRA).

Yamanaka, who shared the 2012 Nobel Prize for Physiology or Medicine with British scientist John Gurdon for discovering that adult stem cells can be transformed into iPS cells, was not among the authors of the study.

“[The misconduct] is something that shakes the people’s trust in research activities and is extremely regrettable,” Japan’s education minister Yoshimasa Hayashi said during the press conference. “We would like to instruct Kyoto University to do its utmost to prevent a recurrence.”

“I am very regretful for not being able to prevent the dishonesty,” Yamanaka told a press conference (via Nikkei Asian Review). “I will take [the incident] seriously and provide education necessary to prevent similar misconduct from happening again.”

Yamanaka says in a statement that Kyoto University is still deliberating disciplinary measures against both Yamamizu and himself. According to Science, Yamanaka suggested that this could involve his resignation—however, some scientists are skeptical that the university would consider this option. “Resignation doesn’t sound like the right thing to happen in this situation,” Alan Trounson, a stem cell researcher at Australia’s Hudson Institute of Medical Research, tells Science

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.